Intellectual Property India Publishes Patent Application for 'Drug Formulations Of (R)-1-(1-Acryloylpiperidin-3-Yl)-4-Amino-3-(4- Phenoxyphenyl)-1H-Imidazo[4,5- C]Pyridin-2(3H)-One' Filed by Principia Biopharma Inc.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517057792 A) filed by Principia Biopharma Inc., Bridgewater, U.S.A., on June 16, for 'drug formulations of (r)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4- phenoxyphenyl)-1h-imidazo[4,5- c]pyridin-2(3h)-one.'

Inventor(s) include Calderone, Marilyn; and Viault, Caroline.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "This disclosure relates to the field of therapeutic Bruton's tyrosine kinase (BTK) inhibitors. Pharmaceutical formulations of (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one are described."

The patent application was internationally filed on Dec. 19, 2023, under International application No.PCT/US2023/084784.

Disclaimer: Curated by HT Syndication.